Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biotechnology and Development ApS
APS
Active
CVR 33870639
Priorsvej 4A, 8600
Silkeborg
Wholesale of other intermediate products
·
NACE 4686
Est. 2011 · 14 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of other intermediate products
/
Biotechnology and Development ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-7
45
3
108
282
Staff expenses
-24
-22
-22
-23
-284
EBITDA
-31
23
-19
85
-2
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-31
23
-19
85
-2
Net financials
3
1
-0
-0
-0
Profit before tax
-28
24
-19
85
-2
Tax
-6
5
-4
19
-0
Net profit
-22
19
-15
66
-2
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
75
103
78
148
205
Equity
36
55
41
107
105
Long-term debt
0
5
0
15
0
Short-term debt
39
42
37
26
100
Total debt
39
47
37
41
100
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-0.8%
This company
2021
2025
Equity ratio
51.3%
This company
38.2%
Market median
+34% vs market
2021
2025
Return on equity
-1.6%
This company
18.4%
Market median
-109% vs market
2021
2025
Net profit margin (of gross profit)
-0.6%
This company
2021
2025
Asset turnover (of gross profit)
1.38×
This company
2021
2025
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on Biotechnology and Development ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
